AUTUMN BARTENFIELD: Open Payments
NPI 1033425319 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 13 payments from 9 companies in 2025. Trend: 2023 $1,544 · 2024 $335 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Nalu Medical, Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| Averitas Pharma Inc. | 1 | $29 |
| Foundation Fusion Solutions, LLC | 1 | $26 |
| Verona Pharma, Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, Nalu Neurostimulation System, JOURNAVX, QUTENZA, Ohtuvayre, KYPHON EXPRESS II KYPHOPAK TRAY, MOVANTIK.
Industry payments across GA — which companies pay providers there.
